诺舒（NovaSure）阻抗控制子宫内膜切除系统治疗异常子宫出血的临床研究

目的探讨诺舒（NovaSure）阻抗控制子宫内膜切除系统治疗异常子宫出血的可行性、安全性及有效性。方法 2010年6月～11月,采用诺舒治疗异常子宫出血25例,术后1、3、6个月门诊随访,观察疗效及并发症。结果 25例均完成手术过程,NovaSure治疗时间78～122 s,（98.4±9.2）s,术中出血〈10 ml。术后1、3和6个月的有效率分别为100%（25/25）、96%（24/25）和96%（24/25）;闭经率分别为76%（19/25）、64%（16/25）和56%（14/25）。术中及术后均未出现明显并发症。结论诺舒操作简单且安全,疗效好,适用于多种良性疾病所致的异常子宫出血,尤其适用于有严重合并症的患者。

NovaSure System for Abnormal Uterine Bleeding

Objective To investigate the feasibility, safety and efficacy of NovaSure system for abnormal uterine bleeding control. Methods From June 2010 to November 2010, 25 women with abnormal uterine bleeding who received NovaSure system for treatment were retrospectively analyzed. The clinical effect and complications were followed up at raonths 1, 3, and 6. Results The procedures was completed successfully in all the patients. The mean operation time was （98.4 ± 9.2） s （ranged from 78 to 122 s）. During the operation, the blood loss was less than 10 ml. All the patients were followed-up for 6 months. The rate of satisfaction was 100% （25/25）, 96% （24/25）, and 96% （24/25） respectively at months 1, 3, and 6. And the rate of amenorrhea was 76% （19/25）, 64% （ 16/25 ）, and 56% （ 14/25 ）, respectively. No severe perioperative or postoperative complications occurred. Conclusion NovaSure system shows good efficacy, safety and convenience in the treatment of abnormal uterine bleeding, especially for the patients with severe complication.